Emergency Contraceptive Pills Market size is set to grow by USD 240.3 million from 2024-2028, Rise in number of initiatives to create awareness boost the market, Technavio
NEW YORK, June 11, 2024 /PRNewswire/ -- The global emergency contraceptive pills market size is estimated to grow by USD 240.3 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 4.36% during the forecast period. rise in number of initiatives to create awareness is driving market growth, with a trend towards importance of family planning. However, local governments limiting access to emergency contraceptive pills poses a challenge. Key market players include AbbVie Inc., Afaxys Pharma LLC, Bayer AG, Combe Inc., Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd., Knoll Healthcare Pvt. Ltd., Laboratoire HRA Pharma SAS, Lupin Ltd., Mankind Pharma Ltd., Morepen Laboratories Ltd., Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC, and Teva Pharmaceutical Industries Ltd..
Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report
Emergency Contraceptive Pills Market Scope
Report Coverage
Details
Base year 2023
Historic period
2018 - 2022
Forecast period
2024-2028
Growth momentum & CAGR Accelerate at a CAGR of 4.36%
Market growth 2024-2028
USD 240.3 million
Market structure
Fragmented
YoY growth 2022-2023 (%) 4.11
Regional analysis North America, Europe, Asia, and Rest of
World
(ROW)
Performing market contribution North America at 44%
Key countries US, China, Germany, France, and Japan
Key companies profiled AbbVie Inc., Afaxys Pharma LLC, Bayer
AG,
Combe Inc., Foundation Consumer
Healthcare
LLC, Gedeon Richter Plc, HLL Lifecare
Ltd.,
Knoll Healthcare Pvt. Ltd., Laboratoire
HRA
Pharma SAS, Lupin Ltd., Mankind Pharma
Ltd.,
Morepen Laboratories Ltd., Perrigo Co.
Plc,
Pfizer Inc., Piramal Enterprises Ltd.,
Sun
Pharmaceutical Industries Ltd., Syzygy
Healthcare LLC, and Teva Pharmaceutical
Industries Ltd.
Market Driver
The Emergency Contraceptive Pills (ECPs) market is witnessing significant growth due to increasing awareness about family planning in both developed and developing countries. Organizations like the Asia Pacific Council on Contraception, European Society of Cardiology, and International Planned Parenthood Federation are promoting the use of ECPs to prevent unplanned pregnancies and related health risks.
In developing countries, where there is a high unmet need for contraception, government initiatives and easy access to ECPs are increasing their popularity. Effective use of ECPs can prevent morbidity and mortality cases related to pregnancy and abortion.
The Emergency Contraceptive Pills market has seen significant growth in recent years. Active ingredients such as ulipristal acetate and levonorgestrel are commonly used in these pills. Regions like Europe and North America dominate the market due to high awareness and availability of these products. Regions like South America and Asia are expected to show rapid growth in the coming years.
Companies focus on developing new and effective contraceptives to cater to the increasing demand. The use of technology and innovation is a key trend in the market. Condoms and other barrier methods are complementary to emergency contraceptive pills. The regulatory environment is a crucial factor in the market, with strict regulations in place to ensure safety and efficacy.
Research report provides comprehensive data on impact of trend. For more details- Download a Sample Report
Market Challenges
-- The Emergency Contraceptive Pills (ECP) market in the US has faced
restrictions in various forms, impacting its growth. Some states permit
pharmacists to dispense ECPs without prescriptions, while others
prohibit it. Reimbursement policies also vary, with Texas excluding ECPs
from family planning programs. These restrictions limit market
penetration, resulting in potential revenue loss for vendors. States
like Massachusetts and the District of Columbia mandate dispensation in
sexual assault cases. Overall, regulatory and reimbursement policies
significantly influence the ECP market landscape in the US.
-- The Emergency Contraceptive Pills market faces several challenges. These
include the need for rapid distribution and accessibility, particularly
in developing countries. Cost is another significant challenge, with
many individuals unable to afford these essential health products.
-- Regulations and approvals also pose hurdles, as different countries have
varying requirements for marketing and selling emergency contraceptives.
Additionally, the stigma surrounding the use of these pills can limit
their adoption, particularly in conservative societies. To address these
challenges, stakeholders must collaborate to improve access,
affordability, and education about the importance and benefits of
emergency contraceptives.
For more insights on driver and challenges - Request a sample report!
Segment Overview
1. Distribution Channel
-- 1.1 Retail stores
-- 1.2 Online stores
2. Type
-- 2.1 Combination pills
-- 2.2 Progesterone pills
3. Geography
-- 3.1 North America
-- 3.2 Europe
-- 3.3 Asia
-- 3.4 Rest of World (ROW)
1.1 Retail stores- The retail sector, including supermarkets, hypermarkets, department stores, pharmacies, and clinics, plays a significant role in the global emergency contraceptive pills market. Retailers, such as Walmart, Walgreens, and CVS Pharmacy, sell these pills, including Plan B One-Step by Foundation Consumer Healthcare. Retailers focus on enhancing consumer trust and confidence in purchases. Increased disposable income and promotional offers contribute to market growth. Contraceptive products drive footfall due to a wide range of options. However, availability in Asia is limited to pharmacies, and online sales will only marginally impact retail sales.
For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) - Download a Sample Report
Research Analysis
The Emergency Contraceptive Pills (ECP) market, driven by increased unprotected sex and evolving reproductive health services, is experiencing significant demand. Drospirenone tablets, such as Slynd, along with Drovelis and Plan B, are pivotal in this sector. Research by the American Chemical Society underscores their efficacy, particularly compared to combined oral contraceptives. With rising abortion restrictions, reliance on ECPs has surged, positioning them as crucial pre-coital contraceptives. Manufacturers like Organon and Gedeon Richter lead in providing these essential OTC products. While condoms and birth control pills remain vital, ECPs are indispensable for preventing unintended pregnancies.
Market Research Overview
The global Emergency Contraceptive Pills (ECP) market is witnessing significant growth driven by rising awareness and acceptance of post-coital contraceptives. Increased sexual activity among young adults and the availability of over-the-counter ECPs and condoms further fuel this demand. ECPs prevent unintended pregnancies by inhibiting ovulation, fertilization, or implantation of a fertilized egg. Market segmentation includes product type, distribution channel, and region. As the need for effective and convenient contraceptive solutions rises, the ECP market is poised for steady expansion, reflecting a critical component in modern reproductive health strategies.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
-- Distribution Channel
-- Retail Stores
-- Online Stores
-- Type
-- Combination Pills
-- Progesterone Pills
-- Geography
-- North America
-- Europe
-- Asia
-- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/emergency-contraceptive-pills-market-size-is-set-to-grow-by-usd-240-3-million-from-2024-2028--rise-in-number-of-initiatives-to-create-awareness-boost-the-market-technavio-302169136.html
SOURCE Technavio
